Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethoxzolamide (L-643786) is a carbonic anhydrase inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 33.00 | |
10 mg | In stock | $ 44.00 | |
25 mg | In stock | $ 68.00 | |
50 mg | In stock | Inquiry |
Description | Ethoxzolamide (L-643786) is a carbonic anhydrase inhibitor. |
Targets&IC50 | CA:1nM(Ki) |
In vitro | Ethoxzolamide (ETZ) treatment leads to a greater than 90% reduction in reporter GFP fluorescence in infected macrophages and markedly impairs the intracellular growth of M. tuberculosis, as demonstrated in a 9-day macrophage survival assay. |
Synonyms | PNU-4191, Redupresin, L-643786 |
Molecular Weight | 258.32 |
Formula | C9H10N2O3S2 |
CAS No. | 452-35-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 150 mg/mL (580.68 mM), Sonication and heating are recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ethoxzolamide 452-35-7 Metabolism Microbiology/Virology Carbonic Anhydrase Antibacterial Carbonate dehydratase inhibit PNU-4191 Inhibitor PNU 4191 Bacterial PNU4191 Redupresin L 643786 L-643786 L643786 inhibitor